Search

everythinglearnresearchcommunity

for

Search:↓

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

Melatonin may help treat PCOS symptoms in rats.

Women with mild acne are more likely to have polycystic ovary syndrome (PCOS) than those without acne.

Losing 5-10% body weight can improve PCOS symptoms, letrozole is better than clomiphene for fertility, and managing weight and blood sugar is important to reduce pregnancy complications.

Excessive hair growth in women can be harmless or signal serious health issues, and treatment often includes medication and hair removal, with noticeable results after 3-6 months.

Early diagnosis and treatment of PCOS in young people is important to prevent long-term health problems.

Platelet-rich plasma infusion improved pregnancy outcomes for women with thin endometrium.

Mesenchymal stromal cell therapies show promise for treating various diseases but need more research and standardization.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Mesenchymal stem cells may effectively treat and prevent allergic skin conditions.

Operative hysteroscopy is still the main treatment for Asherman syndrome, but more research is needed on post-surgery methods.

The document concludes that early and personalized treatment for PCOS in adolescents is crucial to manage symptoms and prevent long-term health issues.

Letrozole is better for single follicle development and endometrial thickness in PCOS, with no significant difference in pregnancy rates compared to clomiphene.

The woman's surgery lowered her testosterone and improved scalp hair loss but did not change her excessive body hair.

High androgen levels can cause excessive hair growth and may indicate serious health issues, including heart disease and fertility problems.

Removing both ovaries may better treat increased male hormone levels and related symptoms in postmenopausal women when hormone therapy doesn't work.

Postmenopausal virilization can be caused by ovarian hyperthecosis, treatable with surgery.

Women with PCOS face many health risks, but exercise, a healthy diet, and weight management can help.

Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.

Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.

PCOS is linked to a higher risk of endometrial cancer but not ovarian or breast cancer, and more research is needed on its role in cancer development and treatment effects.

Chemotherapy provides symptom relief and extends life in 30-50% of gynecological cancer cases, but has only cured choriocarcinoma.

IFNγ-primed MSC secretomes can improve joint health by reducing inflammation and supporting tissue repair.

The research found that MRI and certain hormone levels can help tell apart ovarian tumors from hyperthecosis in postmenopausal women, but tissue analysis is still needed for a definite diagnosis.

Budesonide and N-acetylcysteine reduced tumors and alopecia in mice, regardless of FHIT gene status.

Platelet-rich plasma can help thicken the endometrium and improve pregnancy rates.

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.

KGF and its receptor are found in enlarged prostate tissue and KGF strongly increases cell growth.

Human fetal placental stromal cell injections speed up healing and improve skin and hair recovery after radiation damage.

Enhancing glycolysis in mesenchymal stromal/stem cells boosts their immune functions and therapy potential.